SCHEMBL25979705

SCHEMBL25979705

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc4c(c3)oc3cc(-c5ccc(N(c6ccccc6)c6ccc7c(c6)oc6ccccc67)cc5)ccc34)n2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP12 P39900 1/20 0.40
MMP13 P45452 1/20 0.40
HCRTR1 O43613 1/20 0.38
AHR P35869 2/20 0.38
MAPT P10636 6/20 0.37
ALDH1A1 P00352 4/20 0.37
KMT2A Q03164 4/20 0.37
KDM4E B2RXH2 3/20 0.37
HPGD P15428 3/20 0.37
MEN1 O00255 3/20 0.37
PLA2G2A P14555 2/20 0.36
PLA2G4A P47712 2/20 0.36
POLB P06746 2/20 0.36
PDE5A O76074 2/20 0.35
LMNA P02545 2/20 0.35
TSHR P16473 2/20 0.35
TTR P02766 1/20 0.35
CYP1A2 P05177 1/20 0.35
GLA P06280 1/20 0.35
CYP3A4 P08684 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25979910 0.99 AHR (0.39) MMP12MMP13HCRTR1AHRMAPT
SCHEMBL25979515 0.97 AHR (0.40) MMP12MMP13HCRTR1AHRMAPT
SCHEMBL25979097 0.96 PLA2G2A (0.40) MMP12MMP13HCRTR1AHRMAPT
SCHEMBL24255832 0.96 AHR (0.41) MMP12MMP13HCRTR1AHRMAPT
SCHEMBL25979907 0.96 MAPT (0.36) MMP12MMP13HCRTR1MAPTALDH1A1
SCHEMBL26571587 0.96 AHR (0.41) HCRTR1AHRMAPTALDH1A1KMT2A
SCHEMBL24255837 0.96 AHR (0.41) MMP12MMP13HCRTR1AHRMAPT
SCHEMBL24255834 0.95 PLA2G2A (0.39) MMP12MMP13HCRTR1AHRMAPT
SCHEMBL25979932 0.95 PLA2G2A (0.38) MMP12MMP13HCRTR1AHRMAPT
SCHEMBL21117093 0.95 AHR (0.41) MMP12MMP13HCRTR1AHRMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-11-16 US disclosed
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-11-16 US disclosed
EP-4227301-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT Materials Co., Ltd. (KR) 2023-08-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, CYP1A1, CYP1B1 MMP12 4355/4885MMP13 4837/4885HCRTR1 549/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.